Christopher Schott
JPMorgan Chase & Co, Research Division
Good afternoon, everybody. I’m Chris Schott at JPMorgan, and it’s my pleasure to be introducing Regeneron today. From the company, we have Regeneron’s Co-Founders and Co-Chairs President and CEO, Len Schleifer; and President and CSO, George Yancopoulos. Between the core portfolio and an increasingly broad pipeline, I’m very much looking forward to the presentation today. So with that, over to Len, and we’ll go to some Q&A after that.
Leonard Schleifer
Co-Founder, President, CEO & Co-Chairman
Thanks, Chris. It’s great to be here. We’re going to try and do maybe 20 minutes of presentation and then leave it to you for questions. It’s great to be back in San Francisco for the 44th I guess JPMorgan Conference. .
We think it’s a very interesting conference. It mainly got interesting 37 years ago when we started presenting. We have been in every room at the conference. And in every single room many times the most common phrase that we have heard, so it shows how consistent the place is, is promising data.
Okay. We — that went over well. That’s my team said, don’t do it Len. Anyway, I’m Len Schleifer, CEO of Regeneron. I’m joined on stage by my longtime partner Regeneron, Dr. George Yancopoulos, Regeneron’s Chief Scientific Officer and Co-Founder. During our presentation, we will be referring to slides, which may be found on our website.
This is one of my — this one is one of my favorite slides. It contains our forward-looking statements. There’s
